您好,欢迎光临上海雅吉生物商城!
工作时间:9:00-18:00
全国服务热线:021-34661276

PE/Cyanine7 anti-human CD45RO Antibody

规格
价格库存
订购热线:021-34661276
我要询价
  • 商品详情
  • 售后服务
  • 相关文献

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee, Cynomolgus, Common Marmoset
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
IL-2 dependent T cell line, CA1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The UCHL1 antibody is commonly used in combination with antibodies against CD45RA to discern memory and na?ve T cells. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections5 and formalin-fixed paraffin-embedded tissue sections4, Western blotting2, and immunoprecipitation3.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York. (FC)
  2. Ishii T, et al. 2001. P. Natl. Acad. Sci. USA 98:12138. (WB)
  3. Ponsford M, et al. 2001. Clin. Exp. Immunol. 124:315. (IP)
  4. Yamada M, et al. 1996. Stroke 27:1155. (IHC)
  5. Sakkas LI, et al. 1998. Clin. Diagn. Lab. Immunol. 5:430. (IHC)
  6. Baba N, et al. 2010. Int. Immunol. 22:237. PubMed
  7. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
  8. Weiss L, et al. 2010. P. Natl. Acad. Sci. USA 107:10632. PubMed
  9. Wu YY, et al. 2007. Infect. Immun. 75:4357. PubMed
  10. Mozaffarian N, et al. 2008. Rheumatology 47:1335. PubMed
  11. Roque S, et al. 2007. J. Immunol. 178:8028. PubMed
  12. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  13. Smith SH, et al. 1986. Immunology 58:63. (Immunogen)
  14. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Gordeychuk IV, et al. 2019. Acta Naturae. 10:63. PubMed
  2. Kieffer T, et al. 2017. J Reprod Immunol. 10.1016/j.jri.2016.11.004. PubMed
  3. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  4. Traitanon O, et al. 2015. PLoS One. 10:129658. PubMed
  5. Kraig E, et al. 2018. Exp Gerontol. 105:53. PubMed
  6. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  7. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  8. Zhou WJ, et al. 2021. Theranostics. 11:5330. PubMed
  9. Gurusamy D, et al. 2020. Cancer Cell. 37(6):818-833.e9. PubMed
  10. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  11. Audigé A, et al. 2017. BMC Immunology. 10.1186/s12865-017-0209-9. PubMed
  12. Jiang W, et al. 2014. J Virol. 88:5369. PubMed
  13. Müller TR, et al. 2021. Cell Rep Med. 2:100374. PubMed
  14. Leeansyah E, et al. 2014. Nat Commun. 5:3143. PubMed
  15. Huang L, et al. 2017. Immun Ageing. 10.1186/s12979-017-0096-1. PubMed
  16. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
  17. Koh WH, et al. 2020. STAR Protoc. 1:100203. PubMed
  18. Delmas A, et al. 2016. PLoS One. 11: 0163305. PubMed
  19. Zhai Y, et al. 2018. Autophagy. 1.714583333. PubMed
  20. Mann EH, et al. 2019. J Immunol. 202:684. PubMed
RRID
AB_11203903 (BioLegend Cat. No. 304229) AB_11203900 (BioLegend Cat. No. 304230)

Antigen Details

Structure
Tyrosine phosphatases, type I transmembrane, 180 kD (isoform of CD45 containing none of the A, B, or C determinants)
Distribution

Activated and memory T cells, B cell subsets, monocytes, macrophages, granulocytes

Function
Enhances TCR and BCR signaling
Ligand/Receptor
CD22
Cell Type
B cells, Granulocytes, Macrophages, Mesenchymal Stem Cells, Monocytes, T cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Thomas M. 1989. Annu. Rev. Immunol. 7:339.
2. Trowbridge I, et al. 1994. Annu. Rev. Immunol. 12:85.

Gene ID
5788 View all products for this Gene ID
UniProt
View information about CD45RO on UniProt.org
我要询价
*联系方式:
(可以是QQ、MSN、电子邮箱、电话等,您的联系方式不会被公开)
*内容:


微信客服
扫一扫立即咨询


微信客服
扫一扫立即咨询

销售电话:

021-34661275

021-34661276

15301693058